These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 31181961)

  • 61. Isoniazid tuberculosis preventive therapy in HIV-infected adults accessing antiretroviral therapy: a Botswana Experience, 2004-2006.
    Mosimaneotsile B; Mathoma A; Chengeta B; Nyirenda S; Agizew TB; Tedla Z; Motsamai OI; Kilmarx PH; Wells CD; Samandari T
    J Acquir Immune Defic Syndr; 2010 May; 54(1):71-7. PubMed ID: 19934764
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The impact of isoniazid preventive therapy and antiretroviral therapy on tuberculosis in children infected with HIV in a high tuberculosis incidence setting.
    Frigati LJ; Kranzer K; Cotton MF; Schaaf HS; Lombard CJ; Zar HJ
    Thorax; 2011 Jun; 66(6):496-501. PubMed ID: 21460373
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Interventions to improve delivery of isoniazid preventive therapy: an overview of systematic reviews.
    Adams LV; Talbot EA; Odato K; Blunt H; Steingart KR
    BMC Infect Dis; 2014 May; 14():281. PubMed ID: 24886159
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Implementing isoniazid preventive therapy in a tuberculosis treatment-experienced cohort on ART.
    Maharaj B; Gengiah TN; Yende-Zuma N; Gengiah S; Naidoo A; Naidoo K
    Int J Tuberc Lung Dis; 2017 May; 21(5):537-543. PubMed ID: 28399969
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Safety and Effectiveness of Isoniazid Preventive Therapy in Pregnant Women Living with Human Immunodeficiency Virus on Antiretroviral Therapy: An Observational Study Using Linked Population Data.
    Kalk E; Heekes A; Mehta U; de Waal R; Jacob N; Cohen K; Myer L; Davies MA; Maartens G; Boulle A
    Clin Infect Dis; 2020 Nov; 71(8):e351-e358. PubMed ID: 31900473
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Tuberculosis case finding and isoniazid preventive therapy among people living with HIV at public health facilities of Addis Ababa, Ethiopia: a cross-sectional facility based study.
    Denegetu AW; Dolamo BL
    BMC Public Health; 2014 Jan; 14():52. PubMed ID: 24438508
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Improving coverage and completion rate of isoniazid preventive therapy among eligible HIV patients using quality improvement approaches: a case study of State Hospital, Ijebu Ode, Ogun State, Nigeria.
    Ogunsola OO; Ajayi O; Ojo O; Adeyeye O; Akinro Y; Oke O; Adurogbola AA; Olajide O
    Pan Afr Med J; 2019; 34():193. PubMed ID: 32180867
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effectiveness of isoniazid preventive therapy on incidence of tuberculosis among HIV-infected adults in programme setting.
    Padmapriyadarsini C; Sekar L; Reddy D; Chitra A; Poornagangadevi N; Selvaraj M; Bhavani PK; Mothi SN; Nandagopal K; Vennila S; Tamizhselvan M; Maheshmanisha J; Agarwal U; Rewari BB; Swaminathan S
    Indian J Med Res; 2020 Dec; 152(6):648-655. PubMed ID: 34145105
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effect of isoniazid preventive therapy on tuberculosis or death in persons with HIV: a retrospective cohort study.
    Ayele HT; van Mourik MS; Bonten MJ
    BMC Infect Dis; 2015 Aug; 15():334. PubMed ID: 26269094
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Barriers and Facilitators of Isoniazid Preventive Therapy Implementation among People Living with HIV in Nigeria: A Scoping Review of the Literature.
    Adepoju VA; Adelekan A; Adepoju OE; Onyezue OI; Imoyera W; Nkeiruka A; Olofinbiyi AB
    West Afr J Med; 2023 Mar; 40(3):336-344. PubMed ID: 37018383
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Isoniazid preventive therapy in HIV-infected and -uninfected children (0 - 14 years).
    Schaaf HS; Cotton MF; Boon GP; Jeena PM
    S Afr Med J; 2013 Sep; 103(10):714-5. PubMed ID: 24079619
    [TBL] [Abstract][Full Text] [Related]  

  • 72. High Burden of Adverse Drug Reactions to Isoniazid Preventive Therapy in People Living With HIV at 3 Tertiary Hospitals in Uganda: Associated Factors.
    Nanyonga SM; Kitutu FE; Kalyango J; Frank M; Kiguba R
    J Acquir Immune Defic Syndr; 2022 Feb; 89(2):215-221. PubMed ID: 34693930
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Anti-tuberculosis treatment outcomes in HIV-infected adults exposed to isoniazid preventive therapy in Botswana.
    Sibanda T; Tedla Z; Nyirenda S; Agizew T; Marape M; Miranda AG; Reuter H; Johnson JL; Samandari T
    Int J Tuberc Lung Dis; 2013 Feb; 17(2):178-85. PubMed ID: 23317952
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Acceptability and adherence to Isoniazid preventive therapy in HIV-infected patients clinically screened for latent tuberculosis in Dar es Salaam, Tanzania.
    Shayo GA; Moshiro C; Aboud S; Bakari M; Mugusi FM
    BMC Infect Dis; 2015 Aug; 15():368. PubMed ID: 26306511
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Implementation and evaluation of an isoniazid preventive therapy pilot program among HIV-infected patients in Vietnam, 2008-2010.
    Trinh TT; Han DT; Bloss E; Le TH; Vu TT; Mai AH; Nguyen NV; Nguyen LT; Dinh SN; Whitehead S
    Trans R Soc Trop Med Hyg; 2015 Oct; 109(10):653-9. PubMed ID: 26385936
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The effect of isoniazid preventive therapy on incidence of tuberculosis among HIV-infected clients under pre-ART care, Jimma, Ethiopia: a retrospective cohort study.
    Assebe LF; Reda HL; Wubeneh AD; Lerebo WT; Lambert SM
    BMC Public Health; 2015 Apr; 15():346. PubMed ID: 25886730
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Empirical tuberculosis therapy versus isoniazid in adult outpatients with advanced HIV initiating antiretroviral therapy (REMEMBER): a multicountry open-label randomised controlled trial.
    Hosseinipour MC; Bisson GP; Miyahara S; Sun X; Moses A; Riviere C; Kirui FK; Badal-Faesen S; Lagat D; Nyirenda M; Naidoo K; Hakim J; Mugyenyi P; Henostroza G; Leger PD; Lama JR; Mohapi L; Alave J; Mave V; Veloso VG; Pillay S; Kumarasamy N; Bao J; Hogg E; Jones L; Zolopa A; Kumwenda J; Gupta A;
    Lancet; 2016 Mar; 387(10024):1198-209. PubMed ID: 27025337
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Knowledge and adherence to isoniazid preventive therapy among people living with HIV in multilevel health facilities in South-East, Nigeria: baseline findings from a quasi-experimental study.
    Akamike IC; Okedo-Alex IN; Agu AP; Alo C; Ogbonnaya LU
    Pan Afr Med J; 2020; 36():261. PubMed ID: 33014257
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Preventive chemotherapy for HIV-associated tuberculosis in Uganda: an operational assessment at a voluntary counselling and testing centre.
    Aisu T; Raviglione MC; van Praag E; Eriki P; Narain JP; Barugahare L; Tembo G; McFarland D; Engwau FA
    AIDS; 1995 Mar; 9(3):267-73. PubMed ID: 7755915
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Implementing an isoniazid preventive therapy program for people living with HIV in Thailand.
    Danyuttapolchai J; Kittimunkong S; Nateniyom S; Painujit S; Klinbuayaem V; Maipanich N; Maokamnerd Y; Pevzner E; Whitehead S; Kanphukiew A; Monkongdee P; Martin M
    PLoS One; 2017; 12(9):e0184986. PubMed ID: 28949995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.